|
US4443340A
(en)
|
1981-10-09 |
1984-04-17 |
Betz Laboratories, Inc. |
Control of iron induced fouling in water systems
|
|
US5100899A
(en)
|
1989-06-06 |
1992-03-31 |
Roy Calne |
Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
|
|
JPH04230389A
(ja)
|
1990-07-16 |
1992-08-19 |
American Home Prod Corp |
ラパマイシン誘導体
|
|
US5023262A
(en)
|
1990-08-14 |
1991-06-11 |
American Home Products Corporation |
Hydrogenated rapamycin derivatives
|
|
PT98990A
(pt)
|
1990-09-19 |
1992-08-31 |
American Home Prod |
Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
US5120842A
(en)
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
|
US5120727A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Rapamycin dimers
|
|
US5120725A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Bicyclic rapamycins
|
|
IL102414A
(en)
|
1991-07-25 |
1996-08-04 |
Univ Louisville Res Found |
Medicinal preparations for the treatment of ocular inflammation, containing rapamycin
|
|
WO1993012160A1
(fr)
|
1991-12-19 |
1993-06-24 |
Mitsui Toatsu Chemicals, Inc. |
Acide polyhydroxy carboxylique et son procede de production
|
|
US5177203A
(en)
|
1992-03-05 |
1993-01-05 |
American Home Products Corporation |
Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
|
|
US5242910A
(en)
|
1992-10-13 |
1993-09-07 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontal disease
|
|
US5536729A
(en)
|
1993-09-30 |
1996-07-16 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
|
US5527907A
(en)
|
1993-11-19 |
1996-06-18 |
Abbott Laboratories |
Macrolide immunomodulators
|
|
US5968542A
(en)
|
1995-06-07 |
1999-10-19 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system as a device
|
|
US7833543B2
(en)
*
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
EP1006935B1
(en)
*
|
1995-06-07 |
2005-01-26 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
|
US5747058A
(en)
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
|
US5989591A
(en)
|
1997-03-14 |
1999-11-23 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
|
US6890546B2
(en)
|
1998-09-24 |
2005-05-10 |
Abbott Laboratories |
Medical devices containing rapamycin analogs
|
|
US6015815A
(en)
|
1997-09-26 |
2000-01-18 |
Abbott Laboratories |
Tetrazole-containing rapamycin analogs with shortened half-lives
|
|
US6376517B1
(en)
|
1998-08-14 |
2002-04-23 |
Gpi Nil Holdings, Inc. |
Pipecolic acid derivatives for vision and memory disorders
|
|
WO2002067991A1
(en)
|
2001-02-23 |
2002-09-06 |
Genentech, Inc. |
Erodible polymers for injection
|
|
AU2003256849A1
(en)
|
2002-07-31 |
2004-02-16 |
Alza Corporation |
Injectable multimodal polymer depot compositions and uses thereof
|
|
ES2428354T3
(es)
|
2002-09-18 |
2013-11-07 |
Trustees Of The University Of Pennsylvania |
Rapamicina para usar en la inhibición o prevención de la neovascularización coroidea
|
|
JP2006508127A
(ja)
|
2002-11-06 |
2006-03-09 |
アルザ・コーポレーション |
制御された放出性デポー剤配合物
|
|
ES2553136T3
(es)
|
2002-12-13 |
2015-12-04 |
Durect Corporation |
Sistema de administración oral de fármacos que comprende materiales vehículos líquidos de alta viscosidad
|
|
CA2518791A1
(en)
|
2003-03-11 |
2004-09-23 |
Qlt Usa Inc. |
Formulations for cell-schedule dependent anticancer agents
|
|
CN1882338A
(zh)
|
2003-09-18 |
2006-12-20 |
马库赛特公司 |
经巩膜递送
|
|
US7087237B2
(en)
*
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
ATE537844T1
(de)
*
|
2004-09-17 |
2012-01-15 |
Durect Corp |
Dauerhafte lokalanästhetische zusammensetzung mit saib
|
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
EP3173072A1
(en)
|
2004-10-01 |
2017-05-31 |
Ramscor, Inc. |
Conveniently implantable sustained release drug compositions
|
|
US8313763B2
(en)
*
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
|
JP4974903B2
(ja)
|
2005-02-09 |
2012-07-11 |
参天製薬株式会社 |
疾患または状態を処置するための液体処方物
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
WO2006102378A2
(en)
*
|
2005-03-21 |
2006-09-28 |
Macusight, Inc. |
Drug delivery systems for treatment of diseases or conditions
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
JP5528708B2
(ja)
|
2006-02-09 |
2014-06-25 |
参天製薬株式会社 |
安定な製剤ならびにそれらを調製および使用する方法
|
|
JP5506378B2
(ja)
|
2006-03-23 |
2014-05-28 |
参天製薬株式会社 |
血管透過性に関連する疾患または病気のための製剤および方法
|
|
CN1973822A
(zh)
|
2006-12-20 |
2007-06-06 |
山东蓝金生物工程有限公司 |
一种含雷帕霉素的抗癌组合物
|
|
JP5452230B2
(ja)
|
2006-12-21 |
2014-03-26 |
ストライカー コーポレイション |
生物学的因子の結晶、高分子ゲルおよび粒子懸濁液を含む持続放出処方物
|
|
JP5599705B2
(ja)
|
2007-05-18 |
2014-10-01 |
デュレクト コーポレーション |
改良されたデポー製剤
|
|
EP2187743B1
(en)
*
|
2007-08-16 |
2014-07-30 |
Santen Pharmaceutical Co., Ltd |
Rapamycin formulations for treatment of age related macular degeneration
|
|
EP2219622A1
(en)
|
2007-12-06 |
2010-08-25 |
Durect Corporation |
Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
|
|
CA2714514C
(en)
*
|
2008-02-08 |
2016-08-16 |
Qps Llc |
Non-polymeric compositions for controlled drug delivery
|
|
WO2010129622A1
(en)
|
2009-05-04 |
2010-11-11 |
Macusight, Inc. |
Mtor pathway inhibitors for treating ocular disorders
|
|
BR112013011967A2
(pt)
*
|
2010-11-24 |
2016-08-30 |
Durect Corp |
composição biodegradável para distribuição de fármaco
|
|
WO2013078396A2
(en)
|
2011-11-23 |
2013-05-30 |
Durect Corporation |
Radiation-sterilized biodegradable drug delivery compositions
|
|
RU2672596C2
(ru)
|
2012-01-23 |
2018-11-16 |
Аллерган, Инк. |
Биологически разлагаемые или биологически разрушаемые микросферы или микрочастицы длительного высвобождения, суспендированные в затвердевающем депообразующем инъекцируемом лекарственном составе
|
|
EA033537B1
(ru)
*
|
2013-03-11 |
2019-10-31 |
Durect Corp |
Инъекционная композиция с контролируемым высвобождением, содержащая жидкий носитель с высокой вязкостью
|
|
JP2016514692A
(ja)
|
2013-03-15 |
2016-05-23 |
デュレクト コーポレーション |
チキソトロピーならびに強化された溶解再現性及び安定性を有する組成物
|
|
JP2016515523A
(ja)
|
2013-03-15 |
2016-05-30 |
デュレクト コーポレーション |
溶解変動性を低減させるためのレオロジー改質剤を有する組成物
|
|
CN110339153A
(zh)
|
2013-05-24 |
2019-10-18 |
爱康生物科技有限公司 |
地塞米松单位剂型、试剂盒及白内障手术后炎症中的应用
|
|
CN115501172A
(zh)
|
2014-11-21 |
2022-12-23 |
丹麦技术大学 |
用于局部药物释放的凝胶制剂
|
|
EP3272362B1
(en)
|
2015-03-18 |
2023-12-13 |
Santen Pharmaceutical Co., Ltd. |
Sustained-release pharmaceutical composition
|
|
CA2991015A1
(en)
|
2015-07-01 |
2017-01-05 |
Santen Pharmaceutical Co., Ltd. |
Depot preparation containing citric acid ester
|
|
KR20190025635A
(ko)
|
2016-06-30 |
2019-03-11 |
듀렉트 코퍼레이션 |
데포 제형
|
|
WO2018128173A1
(en)
|
2017-01-06 |
2018-07-12 |
Santen Pharmaceutical Co., Ltd. |
Intratumoral administration of sirolimus for treatment of prostate cancer
|